Suchergebnisse - "Zheleva, Daniella"

PubPharm (56)

1

Cyclin-dependent kinase inhibitor fadraciclib (CYC065) depletes anti-apoptotic protein and synergizes with venetoclax in primary chronic lymphocytic leukemia cells

enthalten in: Leukemia | 2022

von Chen, R. | Chen, Y. | Xiong, P. | +5

2

Correction to : Interrogation of novel CDK2/9 inhibitor fadraciclib (CYC065) as a potential therapeutic approach for AML

enthalten in: Cell death discovery | 2021

von Chantkran, W. | Hsieh, Y. | Zheleva, D. | +3

ErratumFor: Cell Death Discov. 2021 Jun 10;7(1):137. - PMID 34112754

3

Interrogation of novel CDK2/9 inhibitor fadraciclib (CYC065) as a potential therapeutic approach for AML

enthalten in: Cell death discovery | 2021

von Chantkran, W. | Hsieh, Y. | Zheleva, D. | +3

ErratumIn: Cell Death Discov. 2021 Jul 6;7(1):171. - PMID 34230455

4

Orally bioavailable CDK9/2 inhibitor shows mechanism-based therapeutic potential in MYCN-driven neuroblastoma

enthalten in: The Journal of clinical investigation | 2020

von Poon, E. | Liang, T. | Jamin, Y. | +40

5

Identification and characterization of drug resistance mechanisms in cancer cells against Aurora kinase inhibitors CYC116 and ZM447439

enthalten in: bioRxiv.org | 2020

von Kollareddy, M. | Zheleva, D. | Džubák, P. | +8

6

Fadraciclib (CYC065), a novel CDK inhibitor, targets key pro-survival and oncogenic pathways in cancer

enthalten in: PloS one | 2020

von Frame, S. | Saladino, C. | MacKay, C. | +7

ErratumIn: PLoS One. 2021 May 6;16(5):e0251671. - PMID 33956908

7

Implementing Patient-Derived Xenografts to Assess the Effectiveness of Cyclin-Dependent Kinase Inhibitors in Glioblastoma

enthalten in: Cancers | 2019

von Noonan, J. | Jarzabek, M. | Lincoln, F. | +11

8

Implementing patient-derived xenografts to assess the effectiveness of cyclin-dependent kinase inhibitors in glioblastoma

sonderdruck aus: Cancers | 12 December 2019

von Noonan, J. | Jarzabek, M. | Lincoln, F. | +11

9

DOSAGE REGIMEN FOR SAPACITABINE AND SELICICLIB

enthalten in: Europäisches Patentamt | 2018

von CHIAO JUDY | BLAKE DAVID | ZHELEVA DANIELLA | +3

10

DOSAGE REGIMEN FOR SAPACITABINE AND SELICICLIB

enthalten in: Europäisches Patentamt | 2018

von CHIAO JUDY | BLAKE DAVID | ZHELEVA DANIELLA | +3

1
2
3
4
5
6
Nächster »
[6]